oa Guest Editorial: Continuous Manufacturing at Johnson Matthey For Pharmaceutical Applications

References

1. Z. Brennan, ‘FDA Allows First Switch From Batch to Continuous Manufacturing for HIV Drug’, Regulatory Focus™, Regulatory Affairs Professionals Society, Rockville, Maryland, USA, 12th April, 2016 LINK https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2016/4/fda-allows-first-switch-from-batch-to-continuous-manufacturing-for-hiv-drug [Google Scholar]
2. ‘Quality Considerations for Continuous Manufacturing’, Docket Number: FDA-2019-D-0298, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD, USA, February, 2019 LINK https://www.fda.gov/regulatory-information/search-fda-guidance-documents/quality-considerations-continuous-manufacturing LINK https://www.fda.gov/media/121314/download [Google Scholar]